Key result
Patients aged 75 years and older with STEMI had significantly higher mortality at six months compared to those under 75 years (37.5% vs 0%, p < 0.0001).
Why the study?
Data on STEMI in patients aged over 75 years remain sporadic, and prognosis in these patients is bleak with very high one-year mortality in those over 80 years.
Does age over 75 years affect mortality and access to invasive reperfusion in patients with STEMI?
Cohort (n=63)
No
Does age over 75 years affect mortality and access to invasive reperfusion in patients with STEMI?
Absolute Event Rate: 37.5% vs 0%
p-value: p=<0.0001
Elderly patients over 75 years with STEMI have significantly higher short- and medium-term mortality and receive less invasive reperfusion therapy compared to younger patients.
High one-year mortality in elderly STEMI warrants caution in prehospital care; leaves open optimal strategies for patients over 75.
Data on ST elevation myocardial infarction in patients aged over 75 years remains sporadic. The prognosis for ST Segment Elevation Myocardial Infarction (STEMI) patients is bleak. Mortality at one year in patients aged over 80 years is very high. We describe a series of elderly patients over 75 years treated by emergency physicians in pre-admissions or in emergency wards presenting with acute ST elevation myocardial infarction, and we compare these data with a second group of patients aged below 75 years.
No takes yet. Share an insight, caveat, or question.
Abrar–Ahmad et al. (2018) conducted a cohort in ST Segment Elevation Myocardial Infarction (STEMI) (n=63). Age ≥ 75 years vs. Age < 75 years was evaluated on Mortality at six months (p=<0.0001). Patients aged 75 years and older with STEMI had significantly higher mortality at six months compared to those under 75 years (37.5% vs 0%, p < 0.0001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: